| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.85B | 19.28B | 18.56B | 18.21B | 16.31B | 13.56B |
| Gross Profit | 5.95B | 5.87B | 5.59B | 5.50B | 5.32B | 4.73B |
| EBITDA | 4.55B | 5.07B | 4.97B | 4.71B | 4.53B | 4.05B |
| Net Income | 3.21B | 3.16B | 3.17B | 2.98B | 2.96B | 2.61B |
Balance Sheet | ||||||
| Total Assets | 15.95B | 17.42B | 16.52B | 15.31B | 15.55B | 14.82B |
| Cash, Cash Equivalents and Short-Term Investments | 2.98B | 4.51B | 3.35B | 2.36B | 3.23B | 3.75B |
| Total Debt | 978.64M | 962.00M | 1.00B | 1.01B | 722.00M | 728.00M |
| Total Liabilities | 6.67B | 6.17B | 5.92B | 6.09B | 5.56B | 4.32B |
| Stockholders Equity | 9.24B | 11.21B | 10.56B | 9.17B | 9.94B | 10.44B |
Cash Flow | ||||||
| Free Cash Flow | 3.80B | 4.09B | 2.88B | 2.53B | 3.06B | 2.97B |
| Operating Cash Flow | 4.09B | 4.35B | 3.15B | 2.85B | 3.35B | 3.26B |
| Investing Cash Flow | -50.26M | -361.00M | -708.00M | -218.00M | -1.00B | -1.13B |
| Financing Cash Flow | -4.54B | -2.88B | -2.12B | -3.29B | -3.33B | -1.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $114.21B | 17.31 | 24.82% | 2.25% | 6.58% | 1.19% | |
73 Outperform | $58.00B | 24.55 | 29.68% | 2.58% | 4.62% | 1.06% | |
70 Outperform | $222.48B | 26.07 | 36.86% | 2.21% | 4.51% | 21.89% | |
68 Neutral | $27.70B | 17.90 | 14.84% | 1.46% | 7.44% | -4.57% | |
68 Neutral | $6.46B | 30.32 | 10.27% | ― | 14.26% | -15.49% | |
67 Neutral | $23.05B | 21.25 | 15.49% | 2.78% | -1.97% | 48.61% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |